Antidepressant and Antioxidative Effect of Ibuprofen in the Rotenone Model of Parkinson’s Disease

Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration

(2014) Lívia H. Morais et al.   Pharmacological Reports

Sodium salicylate protects against rotenone-induced Parkinsonism in rats

(2013) Sindhu K. Madathil et al.   SYNAPSE

Inflammation and Adaptive Immunity in Parkinson's Disease

(2013) R. L. Mosley et al.   Cold Spring Harbor Perspectives in Medicine

COX-2 in the neurodegenerative process of Parkinson's disease

(2012) Peter Teismann   BIOFACTORS

The Role of Oxidative Stress in Depressive Disorders

(2012) Tanja Maria Michel et al.   CURRENT PHARMACEUTICAL DESIGN

Classic and New Animal Models of Parkinson's Disease

(2012) Javier Blesa et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Pathogenesis of Parkinson's disease

(2012) Etienne C. Hirsch et al.   MOVEMENT DISORDERS

Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson’s disease

(2012) P. Thakur et al.   NEUROSCIENCE

Mitochondrial functions in astrocytes: Neuroprotective implications from oxidative damage by rotenone

(2012) Ricardo Cabezas et al.   NEUROSCIENCE RESEARCH

Rotenone, Paraquat, and Parkinson’s Disease

(2011) Caroline M. Tanner et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease model

(2011) Won-Seok Choi et al.   JOURNAL OF CELL BIOLOGY

Depression in Parkinson disease—epidemiology, mechanisms and management

(2011) Dag Aarsland et al.   Nature Reviews Neurology

MPP+-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress

(2011) Ya-Ching Hsieh et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Use of ibuprofen and risk of Parkinson disease

(2011) X. Gao et al.   NEUROLOGY

Neurotoxin-based models of Parkinson's disease

(2011) J. Bové et al.   NEUROSCIENCE

Behavioral, Neurochemical and Histological Alterations Promoted by Bilateral Intranigral Rotenone Administration: A New Approach for an Old Neurotoxin

(2011) Camila G. Moreira et al.   NEUROTOXICITY RESEARCH

Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease

(2010) Brandy L. Wilkinson et al.   NEUROBIOLOGY OF AGING

Inflammatory Biomarkers and Depression

(2010) Norbert Müller et al.   NEUROTOXICITY RESEARCH

Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine

(2010) Ronise M. Santiago et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

A highly reproducible rotenone model of Parkinson's disease

(2009) Jason R. Cannon et al.   NEUROBIOLOGY OF DISEASE

The Effects of Piroxicam in the Attenuation of MPP+/MPTP Toxicity In Vitro and In Vivo

(2008) Y. Soliman et al.   NEUROCHEMICAL RESEARCH

Pesticide/Environmental Exposures and Parkinson's Disease in East Texas

(2008) Amanpreet S. Dhillon et al.   Journal of Agromedicine